Insights

Innovative Drug Discovery Enzymlogic specializes in kinetic profiling assays that enable rapid and accurate screening of compounds, making it an ideal partner for pharmaceutical and biotech companies seeking efficient early-stage drug discovery solutions.

Recent Funding and Growth With secured grants totaling over €2.2 million from European and Spanish agencies, Enzymlogic is actively expanding its capabilities and market reach, presenting opportunities to collaborate on cutting-edge projects.

Recognition and Validation Awarded the European Commission’s Seal of Excellence and recognized as an innovative SME, Enzymlogic's credibility and proven track record can facilitate trust and open doors to further partnerships within the biotech ecosystem.

Technological Leadership Leveraging advanced assays and a robust tech stack, Enzymlogic offers high-quality, reproducible kinetic data, which can be highly valuable for clients needing reliable insights to accelerate their drug development pipelines.

Strategic Market Focus Targeting pharmaceutical and biotech sectors, Enzymlogic's platform aligns with the increasing demand for high-throughput, accurate kinetic profiling, creating sales opportunities for companies providing complementary tools or services in early drug discovery phases.

Enzymlogic Tech Stack

Enzymlogic uses 8 technology products and services including cdnjs, CookieYes, oEmbed, and more. Explore Enzymlogic's tech stack below.

  • cdnjs
    Content Delivery Network
  • CookieYes
    Cookie Compliance
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • PWA
    Miscellaneous
  • Apache HTTP Server
    Web Servers
  • AddToAny
    Widgets
  • FlexSlider
    Widgets

Media & News

Enzymlogic's Email Address Formats

Enzymlogic uses at least 1 format(s):
Enzymlogic Email FormatsExamplePercentage
FLast@enzymlogic.comJDoe@enzymlogic.com
50%
FLast@enzymlogic.comJDoe@enzymlogic.com
50%

Frequently Asked Questions

Where is Enzymlogic's headquarters located?

Minus sign iconPlus sign icon
Enzymlogic's main headquarters is located at C/ Santiago Grisolía, 2, Tres Cantos, Madrid 28760, ES. The company has employees across 1 continents, including Europe.

What is Enzymlogic's phone number?

Minus sign iconPlus sign icon
You can contact Enzymlogic's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Enzymlogic's official website and social media links?

Minus sign iconPlus sign icon
Enzymlogic's official website is enzymlogic.com and has social profiles on LinkedInCrunchbase.

What is Enzymlogic's SIC code NAICS code?

Minus sign iconPlus sign icon
Enzymlogic's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Enzymlogic have currently?

Minus sign iconPlus sign icon
As of October 2025, Enzymlogic has approximately 10 employees across 1 continents, including Europe. Key team members include Chief Business Development Officer: J. H.Co-Founder & Ceo: A. C. P.Senior Scientist: N. P.. Explore Enzymlogic's employee directory with LeadIQ.

What industry does Enzymlogic belong to?

Minus sign iconPlus sign icon
Enzymlogic operates in the Biotechnology Research industry.

What technology does Enzymlogic use?

Minus sign iconPlus sign icon
Enzymlogic's tech stack includes cdnjsCookieYesoEmbedGoogle Fonts APIPWAApache HTTP ServerAddToAnyFlexSlider.

What is Enzymlogic's email format?

Minus sign iconPlus sign icon
Enzymlogic's email format typically follows the pattern of FLast@enzymlogic.com. Find more Enzymlogic email formats with LeadIQ.

How much funding has Enzymlogic raised to date?

Minus sign iconPlus sign icon
As of October 2025, Enzymlogic has raised $82K in funding. The last funding round occurred on Jan 01, 2019 for $82K.

When was Enzymlogic founded?

Minus sign iconPlus sign icon
Enzymlogic was founded in 2013.

Enzymlogic

Biotechnology ResearchSpain2-10 Employees

Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery.

We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential.

The insight we provide facilitates the screening of compounds at speed and at scale to iterate medicinal chemistry, understand pharmacokinetics/pharmacodynamics (PK/PD) disconnects and build better models to define therapeutic windows. 

You can email at info@enzymlogic.com to request further information on Enzymlogic’s drug discovery services and partnering information.

#BindingKinetics #drugdiscovery #pharmaceuticals #biotechnology

Section iconCompany Overview

Headquarters
C/ Santiago Grisolía, 2, Tres Cantos, Madrid 28760, ES
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $82K

    Enzymlogic has raised a total of $82K of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2019 in the amount of $82K.

  • $1M

    Enzymlogic's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $82K

    Enzymlogic has raised a total of $82K of funding over 1 rounds. Their latest funding round was raised on Jan 01, 2019 in the amount of $82K.

  • $1M

    Enzymlogic's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.